海辰药业(300584.SZ)：甲硫酸新斯的明注射液获得药品注册批件

Core Viewpoint - Haichen Pharmaceutical has received approval from the National Medical Products Administration for the drug registration certificate of Methanesulfonate Neostigmine Injection, indicating a significant advancement in its product portfolio [1] Group 1: Product Approval - The drug Methanesulfonate Neostigmine Injection is indicated for the antagonism of residual muscle relaxation effects from non-depolarizing muscle relaxants at the end of surgery [1] - It is also used for conditions such as myasthenia gravis, postoperative functional bowel distension, and urinary retention [1]